Standard cholesterol testing only gives you a piece of the picture, leaving many people with “normal” cholesterol numbers unaware that they are still at risk for a heart attack. But that number could grow sharply under far-reaching guidelines detailed by the American Heart Association and the American College of Cardiology. It has already generated a lot of controversy. Those in the group receiving practice guidelines nutritional care (n = 85) had significant changes in HbA(1c) (-0.8%, P = 0.001), fasting plasma glucose (-1.3 mmol\l, P = 0.003) and weight (-5.1 kg, P = 0.05), whereas the patients in the usual nutritional care group (n = 85) had no significant improvements in either HbA(1c) (-0.4%, P = 0.248) or fasting plasma glucose (-0.2 mmol/l, P = 0.638) during the same period. Statins can be used as primary prevention in patients with diabetes who are between 40 and 75 years of age with low-density lipoprotein (LDL) cholesterol levels of 70 to 189 mg/dL, as well as in patients 40 to 75 years of age without diabetes who fall into the high-risk group for atherosclerotic cardiovascular disease (ASCVD), defined by the guideline as a 10-year risk of at least 7.5%. In 2015, MNCM will collect data on LDL for both measures; however, that component will be suppressed from measure calculation and public reporting. Your LDL-cholesterol level greatly affects your risk of heart attack.
Cholesterol is not a nutrient of concern for overconsumption. Guidelines in Practice presents a one hour webinar to support the implementation of the NICE Clinical Guideline (CG181). At present, many diabetic patients do not receive appropriate statin therapy. Speakers include Dr Dermot Neely, Consultant in Clinical Biochemistry and Metabolic Medicine at Newcastle upon Tyne Hospitals NHS Trust and Professor Mike Kirby, visiting Professor Faculty of Health and Human Sciences, Centre for Research in Primary and Community Care, University of Hertfordshire.